HemoCue Glucose 201 RT Manuel D'utilisation page 60

Patent
This product is covered by following patents: SE 9703624-8,
US 6,607,701.
Symbols used
! Caution
Consult instructions for use
CE mark
Class II equipment
Only valid within the European Community.
Indicates separate collection for waste of elec-
trical and electronic equipment.
Serial port
Temperature limitation
To maintain safety use only adapter
marked HCA01
DC inlet
Efficiency level
90
Relative humidity, non-condensing
5
References
• Fogh-Andersen N et al, Approved IFCC
Recommendation on Reporting Results for Blood
Glucose (Abbreviated) Clinical Chemistry 2005;51:9,
1573–1576.
• Atkin et al, Annals of Internal Medicine, 1991, 114;12,
1020–1024.
• Hannestad et al, Accuracy and precise isotope dilution
mass spectrometry method for determining glucose in
whole blood, Clinical Chemistry, 1997; 43:5, 794–800.
• Tietz Fundamentals of Clinical Chemistry: Sixth Edition,
Edited by Burtis CA, Ashwood ER, Bruns DE, 2007;22:393.
• Definition and Diagnosis of Diabetes Mellitus and
Intermediate Hyperglycaemia. Report of a WHO/IDF
Consultation. Geneva: WHO 2006.
• Definition, Diagnosis and Classification of Diabetes
Mellitus and its Complications. Report of a WHO
Consultation. Geneva: WHO 1999.
• American Diabetes Association. Diagnosis and
Classification of Diabetes Mellitus, Diabetes Care, 2006,
29: S43–S48.
• Evaluation of Precision Performance of Quantitative
Measurement Methods, Approved Guideline, CLSI
Document EP5-A2 Vol. 24 No. 25.
• Method Comparison and Bias Estimation Using Patient
Samples, Approved Guideline, CLSI Document EP9-A2
Vol 22 No 19.
• Interference Testing in Clinical Chemistry NCCLS
Approved Guideline; CLSI Document EP7-A2 Vol. 25 No. 27.
• Protocols for Determination of Limits of Detection and
Limit of Quantification, Approved Guideline; CLSI EP17-A
Vol. 24 No. 34.
60